Award Notice - W81K00-23-Q-0124 - Solicitation for Human papillomavirus High Risk testing, detection, and genotyping (genotypes 16 & 18) for the Brooke Army Medical Center (BAMC), Fort Sam Houston, Texas
Award Notice Posted
- Solicitation number
- W81K00-23-Q-0124
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to Roche Diagnostics Corporation
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81K00-23-P-0198 Federal contract award
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of the Army Medical Command announces the award of contract W81K00-23-Q-0124 to Roche Diagnostics Corporation for $4,205,105. The contract provides for Human papillomavirus High Risk testing, detection, and genotyping (genotypes 16 & 18) services and supplies, including reagents, instruments, consumables, controls, and maintenance for furnished equipment, to conduct HPV DNA Amplification/Detection testing for approximately 4,205 tests at the Department of Pathology & Area Laboratory Services at Brooke Army Medical Center, Fort Sam Houston, Texas.
Notice text
The Government’s requirement was to obtain a cost-per-test (CPT) agreement to include reagents instrument/equipment, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct Human Papillomavirus (HPV) Deoxyribonucleic Acid (DNA) Amplification/Detection test for the Department of Pathology & Area Laboratory Services (DPALS) at the Brooke Army Medical Center (BAMC), Fort Sam Houston, TX.
Awarded contract W81K00-23-P-0198 to ROCHE DIAGNOSTICS CORPORATION for 4205105.00 on 2023-08-22.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity